Assessment of public awareness and perspectives towards adverse drug reaction reporting system in Karachi, Pakistan
PLOS ONE · 2025
DOI: 10.1371/journal.pone.0318139 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Wajiha Iffat und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Dow College of Pharmacy, Dow University of Health Sciences, Karachi, Pakistan. Hauptthemen laut MEDLINE: Adverse Drug Reaction Reporting Systems, Health Knowledge, Attitudes, Practice, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Public involvement in reporting adverse drug reactions (ADRs) generates a broader database on drug safety. Underreporting remains a hindrance to implementing an effective pharmacovigilance system that ultimately affects public health. Hence, it is critical to appraise the public’s awareness of ADR reporting and pharmacovigilance to address the gaps for the enhancement of ADR reporting rate.
Objectives
The current study explored public knowledge and attitudes toward ADR reporting in Karachi, Pakistan.
Methods
A quantitative cross-sectional study was conducted from 3 rd Jan 2022 to 30 th Nov 2022 using a forty-item questionnaire to evaluate public insights regarding the ADR and its reporting. Descriptive analysis was executed to determine frequencies and percentages for the respondents’ baseline characteristics and the responses toward ADR reporting. The chi-square test (χ 2 ) was applied to determine the association between the dependent and independent variables considering a p-value < 0.05 as statistically significant.
Results
The response rate of the present study was 78.3%. More than 80% of the respondents deemed that ADR occurs only with high doses of medicines and over-the-counter medications do not cause any ADR. More than 75% of the respondents did not know that the ADR reporting form is available on the Drug Regulatory Authority of Pakistan (DRAP) website; the response varied significantly with the education (p = 0 . 002) and social status (p = 0 . 0001) of the respondents. More than 50% of the participants refused to ever report an ADR to health professionals. Physicians (n = 364; 47.7%) and pharmacists (n = 253; 33.1%) were the respondents’ professed most reliable sources to whom ADR can be reported; responses varied significantly with their education (p = 0 . 003) and age (p = 0 . 001) .
Conclusions
The study has provided insight into the challenges and gaps needed to improve ADR reporting in Pakistan. The outcomes revealed that the public is aware of the benefits of reporting ADRs; however, they do not realize their role and the potentially significant impact on the healthcare system by contributing to ADR reporting. Therefore, it is a need of time to educate the public on the value of reporting ADRs and implement user-friendly and accessible ADR reporting systems in patient care areas to facilitate easier reporting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Dow College of Pharmacy, Dow University of Health Sciences, Karachi, Pakistan.
- Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Dow College of Pharmacy, Dow University of Health Sciences, Karachi, Pakistan.
- Jinnah College of Pharmacy, Sohail University, Karachi, Pakistan.
- Department of Physiology, Dow University of Health Sciences, Karachi, Pakistan.
- Department of Internal Medicine, Faculty of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.
- Department of Pharmacy Practice, Institute of Pharmaceutical Sciences, Jinnah Sindh Medical University, Karachi, Pakistan.
ORCID-Profile: Sadia Shakeel
Zitieren
APA
Iffat, W., Shakeel, S., Nesar, S., Qamar, A., Huma, Z., Rehman, H., Akhtar, M., Ali, S. A., Ansari, M. N., Yaqoob, M., & Tariq, A. B. (2025). Assessment of public awareness and perspectives towards adverse drug reaction reporting system in Karachi, Pakistan. PLOS ONE. https://doi.org/10.1371/journal.pone.0318139
Vancouver
Iffat W, Shakeel S, Nesar S, Qamar A, Huma Z, Rehman H, et al. Assessment of public awareness and perspectives towards adverse drug reaction reporting system in Karachi, Pakistan. PLOS ONE. 2025. doi:10.1371/journal.pone.0318139
BibTeX
@article{Iffat2025,
author = {Iffat, Wajiha and Shakeel, Sadia and Nesar, Shagufta and Qamar, Ambreen and Huma, Zille and Rehman, Hina and Akhtar, Mahwish and Ali, Syed Ahsan and Ansari, Mohammad Nadeem and Yaqoob, Muhammad and Tariq, Areeb Bin},
title = {Assessment of public awareness and perspectives towards adverse drug reaction reporting system in Karachi, Pakistan},
journal = {PLOS ONE},
year = {2025},
doi = {10.1371/journal.pone.0318139}
}
EUVIMED